CTS CFO sells 25,000 shares under 10b5-1 plan

CTS Corp chief financial officer Ashish Agrawal reported selling 25,000 shares of CTS common stock on 02/02/2026 at $53 per share.

Accepted by SEC EDGAR 02/03/2026 - 04:17 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CTS Corp chief financial officer Ashish Agrawal reported selling 25,000 shares of CTS common stock on 02/02/2026 at $53 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan entered into on February 27, 2025. Following this sale, Agrawal beneficially owns 105,987 CTS common shares directly.

Insider Trade Summary

Net Seller: 25,000 shares

Net Sell 1 txn

Insider Agrawal Ashish

Role CFO

Sold 25,000 shs ($1.32M)

Type	Security	Shares	Price	Value
Sale	Common Stock	25,000	$53.00	$1.32M

Holdings After Transaction: Common Stock — 105,987 shares (Direct)

Footnotes (1)

1. F1. The sale of 25,000 shares reported herein was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on February 27, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CTS (CTS) disclose in this Form 4 filing?

CTS disclosed that CFO Ashish Agrawal sold 25,000 shares of CTS common stock. The sale occurred on February 2, 2026 at a price of $53 per share and was executed under a previously established Rule 10b5-1 trading plan.

How many CTS (CTS) shares does CFO Ashish Agrawal hold after the reported sale?

After the reported transaction, CTS CFO Ashish Agrawal beneficially owns 105,987 shares of CTS common stock. These shares are reported as being held directly, indicating personal ownership following the 25,000-share sale disclosed in the Form 4 filing.

At what price were the CTS (CTS) shares sold in the reported Form 4 transaction?

The 25,000 CTS common shares were sold at a price of $53 per share. This price reflects the executed sale reported for February 2, 2026, and is specifically identified in the Form 4 as the transaction price for the non-derivative common stock.

Was the CTS (CTS) CFO’s stock sale part of a pre-planned trading program?

Yes. The Form 4 explains that the 25,000-share sale was executed under a Rule 10b5-1 trading plan. This trading plan was entered into by CFO Ashish Agrawal on February 27, 2025, establishing predetermined instructions for selling CTS shares.

What role does the reporting person hold at CTS (CTS) in this insider filing?

The reporting person, Ashish Agrawal, serves as chief financial officer of CTS. The Form 4 identifies him as an officer with the title CFO and notes that the transaction involved his directly held CTS common stock rather than indirect or entity-held shares.

Does the CTS (CTS) Form 4 indicate any derivative securities activity for the CFO?

No derivative securities transactions are reported for the CFO in this Form 4. The derivative securities table is present but contains no entries, indicating that only non-derivative common stock, specifically the 25,000-share sale, was reported for this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Agrawal Ashish

(Last) (First) (Middle)

4925 INDIANA AVE

(Street)

LISLE IL 60532

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CTS CORP [ CTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/02/2026		S(1)		25,000	D	$53	105,987	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale of 25,000 shares reported herein was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on February 27, 2025.

	/s/ Debra S. Rouse, attorney-in-fact for Ashish Agrawal	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.